Citation: 叶志鹏, 陈磊. 慢性阻塞性肺疾病合并焦虑抑郁的研究进展. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(5): 491-494. doi: 10.7507/1671-6205.201811011 Copy
1. | Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health. Lancet, 2018, 391(10131): 1706-1717. |
2. | Garvey C, Criner GJ. Impact of comorbidities on the treatment of chronic obstructive pulmonary disease. Am J Med, 2018, 131(9): 23-29. |
3. | 王新安, 刘鲜艳, 欧阳修河. 慢性阻塞性肺疾病合并骨质疏松症研究进展. 中国呼吸与危重监护杂志, 2017, 16(6): 627-630. |
4. | Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: Recognition and management. Clev Clin J Med, 2018, 85(2 Suppl 1): S11-S18. |
5. | 韩萍, 姜文青, 殷彬, 等. COPD合并抑郁症的研究进展. 中国卫生产业, 2016, 13(6): 196-198. |
6. | Regvat J, Mitek A, Vegnuti M, et al. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res, 2011, 39(3): 1028-1038. |
7. | Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr C, 2018, 54(3): 398-404. |
8. | Atlantis E, Fahey P, Cochrane B, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest, 2013, 144(3): 766-777. |
9. | 文富强. 重视慢性阻塞性肺疾病的合并症. 中华肺部疾病杂志(电子版), 2013, 6(2): 99-102. |
10. | Pelgrim CE, Peterson JD, Gosker HR, et al. Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both?. Eur J Pharmacol, 2019, 842: 99-110. |
11. | Zilz C, Blaas SH, Pfeifer M, et al. Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidiscip Respir Med, 2015, 11: 3. |
12. | Pumar MI, Gray CR, Walsh JR, et al. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis, 2014, 6(11): 1615-1631. |
13. | Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res, 2011, 12: 3. |
14. | Xu W, Collet J, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Resp Crit Care, 2008, 178(9): 913-920. |
15. | Usmani ZA, Carson KV, Heslop K, et al. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Db Syst Rev, 2017, 9(3): D10673. |
16. | Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res, 2017, 18(1): 67. |
17. | Xiao T, Qiu H, Chen Y, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry, 2018, 18(1): 89. |
18. | Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med, 2012, 12(1): 53. |
19. | Varol Y, Anar C, Çimen P, et al. Sex-related differences in COPD Assessment Test scores of COPD populations with or without significant anxiety and/or depression. Turk J Med SCI, 2017, 47(1): 61-68. |
20. | Zhang H, Wang X, Lin J, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study. BMJ Open, 2012, 2(2): e844. |
21. | Johnson PL, Samuels BC, Fitz SD, et al. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacol, 2012, 37(8): 1911-1922. |
22. | 文富强, 陈磊. GOLD 2017 更新与中国慢阻肺临床实践. 西部医学, 2018, (1): 1-2. |
23. | Brook A, Zhang C. The role of personal attributes in the genesis and progression of lung disease and cigarette smoking. Am J Public Health, 2013, 103(5): 931-937. |
24. | Sundar IK, Yao H, Huang Y, et al. Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis. PLoS One, 2014, 9(2): e87999. |
25. | Ghaderi A, Nasehghafoori P, Rasouli-Azad M, et al. Examining of thallium in cigarette smokers. Biol Trace Elem Res, 2018, 182(2): 224-230. |
26. | Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrin, 2014, 35(3): 320-330. |
27. | Zhang Q, Liao J, Liao X, et al. Disease knowledge level is a noteworthy risk factor of anxiety and depression in patients with chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm Med, 2014, 14(1): 92. |
28. | Yu T, Ter Riet G, Puhan MA, et al. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Prim Care Respir Med, 2017, 27(1): 36. |
29. | Hyun MK, Lee NR, Jang EJ, et al. Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 747-754. |
30. | Jácome C, Figueiredo D, Gabriel R, et al. Predicting anxiety and depression among family carers of people with chronic obstructive pulmonary disease. Int Psychogeriatr, 2014, 26(7): 1191-1199. |
31. | Mi E, Mi E, Ewing G, et al. Associations between the psychological health of patients and carers in advanced COPD. Int J Chronic Obstruct Obst Dis, 2017, 12: 2813-2821. |
32. | 中华医学会神经病学分会神经心理学与行为神经病学组. 综合医院焦虑、抑郁与躯体化症状诊断治疗的专家共识. 中华神经科杂志, 2016, 49(12): 908-917. |
33. | Vanfleteren LEGW, Spruit MA, Wouters EFM, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med, 2016, 4(11): 911-924. |
34. | Yawn B, Kim V. COPD in primary care: Key considerations for optimized management: Treatment options for stable chronic obstructive pulmonary disease: Current recommendations and unmet needs. J Fam Pract, 2018, 67(2 Suppl): S28-S37. |
35. | Schuler M, Strohmayer M, Muhlig S, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). J Affect Disord, 2018, 232: 268-275. |
36. | Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol, 2015, 216: 35-42. |
37. | 姚文飞, 屠春林, 赵开顺, 等. 慢性阻塞性肺疾病的肺康复研究进展. 临床肺科杂志, 2017, 22(2): 347-350. |
38. | da Silva GP, Nascimento FA, Macêdo TP, et al. Religious coping and religiosity in patients with COPD following pulmonary rehabilitation. Int J Chronic Obstruct Obst Dis, 2018, 13: 175-181. |
39. | Wang L, Mårtensson J, Zhao Y, et al. Experiences of a health coaching self-management program in patients with COPD: a qualitative content analysis. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1527-1536. |
40. | He Y, Zheng Y, Xu C, et al. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J, 2016, 10(3): 318-325. |
41. | Rosa F, Bagnasco A, Ghirotto L, et al. Experiences of older people following an acute exacerbation of chronic obstructive pulmonary disease: a phenomenological study. J Clin Nurs, 2018, 27(5-6): e1110-e1119. |
- 1. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health. Lancet, 2018, 391(10131): 1706-1717.
- 2. Garvey C, Criner GJ. Impact of comorbidities on the treatment of chronic obstructive pulmonary disease. Am J Med, 2018, 131(9): 23-29.
- 3. 王新安, 刘鲜艳, 欧阳修河. 慢性阻塞性肺疾病合并骨质疏松症研究进展. 中国呼吸与危重监护杂志, 2017, 16(6): 627-630.
- 4. Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: Recognition and management. Clev Clin J Med, 2018, 85(2 Suppl 1): S11-S18.
- 5. 韩萍, 姜文青, 殷彬, 等. COPD合并抑郁症的研究进展. 中国卫生产业, 2016, 13(6): 196-198.
- 6. Regvat J, Mitek A, Vegnuti M, et al. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res, 2011, 39(3): 1028-1038.
- 7. Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr C, 2018, 54(3): 398-404.
- 8. Atlantis E, Fahey P, Cochrane B, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest, 2013, 144(3): 766-777.
- 9. 文富强. 重视慢性阻塞性肺疾病的合并症. 中华肺部疾病杂志(电子版), 2013, 6(2): 99-102.
- 10. Pelgrim CE, Peterson JD, Gosker HR, et al. Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both?. Eur J Pharmacol, 2019, 842: 99-110.
- 11. Zilz C, Blaas SH, Pfeifer M, et al. Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidiscip Respir Med, 2015, 11: 3.
- 12. Pumar MI, Gray CR, Walsh JR, et al. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis, 2014, 6(11): 1615-1631.
- 13. Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res, 2011, 12: 3.
- 14. Xu W, Collet J, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Resp Crit Care, 2008, 178(9): 913-920.
- 15. Usmani ZA, Carson KV, Heslop K, et al. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Db Syst Rev, 2017, 9(3): D10673.
- 16. Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res, 2017, 18(1): 67.
- 17. Xiao T, Qiu H, Chen Y, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry, 2018, 18(1): 89.
- 18. Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med, 2012, 12(1): 53.
- 19. Varol Y, Anar C, Çimen P, et al. Sex-related differences in COPD Assessment Test scores of COPD populations with or without significant anxiety and/or depression. Turk J Med SCI, 2017, 47(1): 61-68.
- 20. Zhang H, Wang X, Lin J, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study. BMJ Open, 2012, 2(2): e844.
- 21. Johnson PL, Samuels BC, Fitz SD, et al. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacol, 2012, 37(8): 1911-1922.
- 22. 文富强, 陈磊. GOLD 2017 更新与中国慢阻肺临床实践. 西部医学, 2018, (1): 1-2.
- 23. Brook A, Zhang C. The role of personal attributes in the genesis and progression of lung disease and cigarette smoking. Am J Public Health, 2013, 103(5): 931-937.
- 24. Sundar IK, Yao H, Huang Y, et al. Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis. PLoS One, 2014, 9(2): e87999.
- 25. Ghaderi A, Nasehghafoori P, Rasouli-Azad M, et al. Examining of thallium in cigarette smokers. Biol Trace Elem Res, 2018, 182(2): 224-230.
- 26. Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrin, 2014, 35(3): 320-330.
- 27. Zhang Q, Liao J, Liao X, et al. Disease knowledge level is a noteworthy risk factor of anxiety and depression in patients with chronic obstructive pulmonary disease: a cross-sectional study. BMC Pulm Med, 2014, 14(1): 92.
- 28. Yu T, Ter Riet G, Puhan MA, et al. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Prim Care Respir Med, 2017, 27(1): 36.
- 29. Hyun MK, Lee NR, Jang EJ, et al. Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 747-754.
- 30. Jácome C, Figueiredo D, Gabriel R, et al. Predicting anxiety and depression among family carers of people with chronic obstructive pulmonary disease. Int Psychogeriatr, 2014, 26(7): 1191-1199.
- 31. Mi E, Mi E, Ewing G, et al. Associations between the psychological health of patients and carers in advanced COPD. Int J Chronic Obstruct Obst Dis, 2017, 12: 2813-2821.
- 32. 中华医学会神经病学分会神经心理学与行为神经病学组. 综合医院焦虑、抑郁与躯体化症状诊断治疗的专家共识. 中华神经科杂志, 2016, 49(12): 908-917.
- 33. Vanfleteren LEGW, Spruit MA, Wouters EFM, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med, 2016, 4(11): 911-924.
- 34. Yawn B, Kim V. COPD in primary care: Key considerations for optimized management: Treatment options for stable chronic obstructive pulmonary disease: Current recommendations and unmet needs. J Fam Pract, 2018, 67(2 Suppl): S28-S37.
- 35. Schuler M, Strohmayer M, Muhlig S, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). J Affect Disord, 2018, 232: 268-275.
- 36. Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol, 2015, 216: 35-42.
- 37. 姚文飞, 屠春林, 赵开顺, 等. 慢性阻塞性肺疾病的肺康复研究进展. 临床肺科杂志, 2017, 22(2): 347-350.
- 38. da Silva GP, Nascimento FA, Macêdo TP, et al. Religious coping and religiosity in patients with COPD following pulmonary rehabilitation. Int J Chronic Obstruct Obst Dis, 2018, 13: 175-181.
- 39. Wang L, Mårtensson J, Zhao Y, et al. Experiences of a health coaching self-management program in patients with COPD: a qualitative content analysis. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1527-1536.
- 40. He Y, Zheng Y, Xu C, et al. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J, 2016, 10(3): 318-325.
- 41. Rosa F, Bagnasco A, Ghirotto L, et al. Experiences of older people following an acute exacerbation of chronic obstructive pulmonary disease: a phenomenological study. J Clin Nurs, 2018, 27(5-6): e1110-e1119.
-
Previous Article
弥漫性肺骨化症一例 -
Next Article
青蒿琥酯对哮喘治疗作用的研究进展